LAKE FOREST, Ill. – IDEX Corporation (NYSE: IEX) today announced that its wholly-owned subsidiary, Nano Merger Sub, Inc., has extended the subsequent offering period for its tender offer to acquire all of the remaining untendered and outstanding shares of common stock of Microfluidics International Corporation (OTC Bulletin Board: MFLU). The subsequent offering period has been […]

WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has given notice of its intention to redeem all of the outstanding 3.25% Convertible Senior Subordinated Notes due 2024 (the “Notes”). As of February 25, 2011, $329,229,000 million in aggregate principal amount of the Notes was […]

Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel (IQT). IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community. Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples […]

MILFORD, Mass. – Waters Corporation (NYSE:WAT) announced today that on February 16, 2011, its Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common shares over the next 24 months. The previous $500 million share repurchase program authorized in February 2009 was recently completed. Purchases will be made through […]

Guildford, UK – IDBS, a global provider of innovative enterprise data management, analytics and modeling solutions, announces strong growth in revenue and profitability during the year ended 31 December 2010. This record performance continues the accelerating momentum of recent years and underscores the leading position of IDBS in a growing global market. Financial Highlights (unaudited) […]

SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 833,750 shares of Fluidigm common stock at $13.50 per share, less underwriting discounts and commissions. Together with the shares sold pursuant to the over-allotment option, Fluidigm […]

WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it intends to offer senior notes to fund its acquisition of Dionex Corporation, as well as for general corporate purposes. The aggregate purchase price of the Dionex acquisition, which was announced separately by the company, is estimated […]

BETHESDA, Md. – GE Capital, Healthcare Financial Services announced today that it is agent and a lender for $55 million in senior secured credit facilities for eBioscience, Inc. The credit facilities will be used to finance the company’s repurchase of certain shares from early investors, refinance existing debt, and provide growth capital. The financing includes […]

SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation today announced the pricing of its initial public offering of 5,558,333 shares of its common stock at a price to the public of $13.50 per share. The shares of common stock have been approved to trade on The NASDAQ Global Market under the symbol “FLDM.” Deutsche Bank Securities […]